Extra Super Zhewitra, which is a combination medication containing Vardenafil and Dapoxetine, was approved for use in some countries for the treatment of erectile dysfunction (ED) and premature ejaculation (PE). However, the approval status of medications can change over time as new regulatory decisions are made in different countries. The approval status of Extra Super Zhewitra may vary from country to country based on their respective regulatory processes and guidelines. To obtain the most up-to-date and accurate information regarding the approval status of Extra Super Zhewitra in specific countries, it's best to consult official sources such as the website of the national health regulatory agency or contact a healthcare professional in the respective country. They can provide the most current and reliable information regarding the availability and approval of this medication in their region.